The Evolving Landscape of Biomarkers in Celiac Disease: Leading the Way to Clinical Development.

Smithson, Glennda; Siegelman, Jenifer; Oki, Toshihiko; Maxwell, Joseph R; Leffler, Daniel A

Smithson, Glennda; Siegelman, Jenifer; Oki, Toshihiko; Maxwell, Joseph R; Leffler, Daniel A.

Afiliación

Smithson G; Research and Development, Takeda Pharmaceuticals Inc. Co., Cambridge, MA, United States.
Siegelman J; Research and Development, Takeda Pharmaceuticals Inc. Co., Cambridge, MA, United States.
Oki T; Research and Development, Takeda Pharmaceuticals Inc. Co., Cambridge, MA, United States.
Maxwell JR; Research and Development, Takeda Pharmaceuticals Inc. Co., Cambridge, MA, United States.
Leffler DA; Research and Development, Takeda Pharmaceuticals Inc. Co., Cambridge, MA, United States.

Front Immunol ; 12: 665756, 2021.

Article en En | MEDLINE | ID: mdl-33897715

Asunto(s)

Biomarcadores/análisis; Enfermedad Celíaca/diagnóstico; Enfermedad Celíaca/dietoterapia; Dieta Sin Gluten; Humanos; Mucosa Intestinal/inmunología; Linfocitos T/inmunología

Palabras clave

biomarkers; celiac disease; clinical development; diagnosis; disease monitoring; patient populations

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores / Enfermedad Celíaca Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google